DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 2Dr. Reddy's Laboratories
02 1Olpha
03 32AstraZeneca
04 2Olon S.p.A
05 2TherDose Pharma
Reset all filters
01 1CAPSULE;ORAL
02 1Capsule, hard
03 2Film Coated Tablet
04 2Filmtabl
05 1HARD CAPSULES
06 1Olaparib 50Mg 448 Unita' Oral Use
07 2Oral Solid Dosage Form
08 2TAB
09 2TABLET
10 2TABLET;ORAL
11 1Tablet
12 2Tablets
13 20Blank
Reset all filters
01 1Available Dossier- US-EU-RoW
02 1DISCN
03 1Dossier Readiness:Q3 2026
04 2Lead Market Dossiers- Under Development
05 2Originator
06 2RX
07 30Blank
Reset all filters
01 5LYNPARZA
02 27Lynparza
03 7Blank
Reset all filters
01 20Australia
02 2Canada
03 4India
04 3Italy
05 1Latvia
06 1Norway
07 2South Africa
08 1Sweden
09 2Switzerland
10 3USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness:Q3 2026
Registration Country : Latvia
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LYNPARZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2014-12-19
Application Number : 206162
Regulatory Info : DISCN
Registration Country : USA